KEGG   ORTHOLOGY: K04850
Entry
K04850                      KO                                     

Name
CACNA1C, CAV1.2
Definition
voltage-dependent calcium channel L type alpha-1C
Pathway
ko04010  MAPK signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04260  Cardiac muscle contraction
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04713  Circadian entrainment
ko04720  Long-term potentiation
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04726  Serotonergic synapse
ko04727  GABAergic synapse
ko04728  Dopaminergic synapse
ko04742  Taste transduction
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04921  Oxytocin signaling pathway
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04927  Cortisol synthesis and secretion
ko04929  GnRH secretion
ko04930  Type II diabetes mellitus
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko05010  Alzheimer disease
ko05020  Prion disease
ko05031  Amphetamine addiction
ko05410  Hypertrophic cardiomyopathy
ko05412  Arrhythmogenic right ventricular cardiomyopathy
ko05414  Dilated cardiomyopathy
Disease
H00720  Long QT syndrome
H00728  Brugada syndrome
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04020 Calcium signaling pathway
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04024 cAMP signaling pathway
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04022 cGMP-PKG signaling pathway
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
 09150 Organismal Systems
  09152 Endocrine system
   04911 Insulin secretion
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04929 GnRH secretion
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04912 GnRH signaling pathway
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04921 Oxytocin signaling pathway
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04935 Growth hormone synthesis, secretion and action
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04924 Renin secretion
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04925 Aldosterone synthesis and secretion
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04927 Cortisol synthesis and secretion
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
  09153 Circulatory system
   04260 Cardiac muscle contraction
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04261 Adrenergic signaling in cardiomyocytes
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04270 Vascular smooth muscle contraction
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
  09156 Nervous system
   04724 Glutamatergic synapse
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04727 GABAergic synapse
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04725 Cholinergic synapse
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04728 Dopaminergic synapse
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04726 Serotonergic synapse
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04720 Long-term potentiation
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04723 Retrograde endocannabinoid signaling
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
  09157 Sensory system
   04742 Taste transduction
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
  09159 Environmental adaptation
   04713 Circadian entrainment
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   05020 Prion disease
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
  09165 Substance dependence
   05031 Amphetamine addiction
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
  09166 Cardiovascular disease
   05410 Hypertrophic cardiomyopathy
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   05412 Arrhythmogenic right ventricular cardiomyopathy
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   05414 Dilated cardiomyopathy
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
  09167 Endocrine and metabolic disease
   04930 Type II diabetes mellitus
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
   04934 Cushing syndrome
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
Ion channels [BR:ko04040]
 Voltage-gated cation channels
  Calcium channel, voltage-gated (Cav)
   K04850  CACNA1C, CAV1.2; voltage-dependent calcium channel L type alpha-1C
Other DBs
GO: 0005245
TC: 1.A.1.11.4 1.A.1.11.6
Genes
HSA: 775(CACNA1C)
PTR: 466915(CACNA1C)
PPS: 100971701(CACNA1C)
GGO: 101134060(CACNA1C)
PON: 100442085(CACNA1C)
NLE: 100580437(CACNA1C)
MCC: 721721(CACNA1C)
MCF: 101865175
CSAB: 103218385(CACNA1C)
RRO: 104659017(CACNA1C)
RBB: 108522695(CACNA1C)
CJC: 100406735(CACNA1C)
SBQ: 101040048(CACNA1C)
MMU: 12288(Cacna1c)
MCAL: 110295755(Cacna1c)
MPAH: 110317086(Cacna1c)
RNO: 24239(Cacna1c)
CGE: 100754788(Cacna1c)
NGI: 103739378(Cacna1c)
HGL: 101717129(Cacna1c)
OCU: 100101555(CACNA1C)
CFA: 403516(CACNA1C)
VVP: 112917426(CACNA1C)
AML: 100479715(CACNA1C)
UMR: 103675706(CACNA1C)
UAH: 113258052(CACNA1C)
ORO: 101365624(CACNA1C)
ELK: 111159674
FCA: 101082923(CACNA1C)
PTG: 102956322(CACNA1C)
PPAD: 109276255(CACNA1C)
AJU: 106965473(CACNA1C)
BTA: 408015(CACNA1C)
BOM: 102277590(CACNA1C)
BIU: 109558615(CACNA1C)
BBUB: 102407190(CACNA1C)
CHX: 100861292(CACNA1C)
OAS: 101116562(CACNA1C)
SSC: 100518733(CACNA1C)
CFR: 102524149(CACNA1C)
CDK: 105100748(CACNA1C)
BACU: 103019389(CACNA1C)
LVE: 103087340(CACNA1C)
OOR: 101272740(CACNA1C)
DLE: 111176594(CACNA1C)
PCAD: 102989784(CACNA1C)
ECB: 100049924(CACNA1C)
EAI: 106839455(CACNA1C)
MYB: 102240225(CACNA1C)
MYD: 102753812(CACNA1C)
MNA: 107546425(CACNA1C)
HAI: 109388950(CACNA1C)
DRO: 112309331(CACNA1C)
PALE: 102882682(CACNA1C)
RAY: 107500540(CACNA1C)
MJV: 108387253(CACNA1C)
TMU: 101360945
MDO: 100021421(CACNA1C)
SHR: 100926503
PCW: 110218748(CACNA1C)
OAA: 100082618(CACNA1C)
GGA: 395891(CACNA1C)
CJO: 107315213(CACNA1C)
NMEL: 110395457(CACNA1C)
APLA: 101790062(CACNA1C)
ACYG: 106030933(CACNA1C)
TGU: 100218244(CACNA1C)
LSR: 110472925(CACNA1C)
SCAN: 103820462(CACNA1C)
GFR: 102031898
FAB: 101815051(CACNA1C)
PHI: 102106069(CACNA1C)
PMAJ: 107204397(CACNA1C)
CCAE: 111928486
CCW: 104692245(CACNA1C)
ETL: 114069083(CACNA1C)
FPG: 101916694(CACNA1C)
FCH: 102048150(CACNA1C)
CLV: 102095010(CACNA1C)
EGZ: 104134399(CACNA1C)
NNI: 104020209(CACNA1C)
ACUN: 113475961(CACNA1C)
PADL: 103924366(CACNA1C)
AAM: 106488364(CACNA1C)
ASN: 102377475(CACNA1C)
AMJ: 102575519(CACNA1C)
PSS: 102451554(CACNA1C)
CMY: 102940198(CACNA1C)
CPIC: 101946823(CACNA1C)
ACS: 100553244(cacna1c)
PVT: 110076659(CACNA1C)
PMUR: 107288329(CACNA1C)
PMUA: 114605885
GJA: 107120231(CACNA1C)
XLA: 100462911(cacna1c.S) 108704565
XTR: 100488055(cacna1c)
NPR: 108791575
DRE: 170581(cacna1c)
SRX: 107732972
SANH: 107694143
CCAR: 109104295
IPU: 108279829
PHYP: 113544629
AMEX: 103041474
EEE: 113576556
TRU: 101064574(cacna1c)
LCO: 104940547
MZE: 101471946(cacna1c)
ONL: 100711294(cacna1c)
OLA: 101173517
XMA: 102230290(cacna1c)
XCO: 114161254
PRET: 103459268
CVG: 107095494
NFU: 107385235(cacna1c)
KMR: 108235074
ALIM: 106515158
AOCE: 111571438
CSEM: 103382787(cacna1c)
POV: 109632862
LCF: 108879625
SDU: 111224579(cacna1c)
SLAL: 111658797(cacna1c)
HCQ: 109520063
BPEC: 110162494
MALB: 109959866
ELS: 105023097(cacna1c)
SFM: 108920904(cacna1c)
PKI: 111843125(cacna1c)
LCM: 102357941(CACNA1C)
CMK: 103179419
 » show all
Reference
  Authors
Tiwari S, Zhang Y, Heller J, Abernethy DR, Soldatov NM
  Title
Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit.
  Journal
Proc Natl Acad Sci U S A 103:17024-9 (2006)
DOI:10.1073/pnas.0606539103
  Sequence
[hsa:775]
Reference
PMID:1316612
  Authors
Soldatov NM
  Title
Molecular diversity of L-type Ca2+ channel transcripts in human fibroblasts.
  Journal
Proc Natl Acad Sci U S A 89:4628-32 (1992)
DOI:10.1073/pnas.89.10.4628
  Sequence
[hsa:775]

KEGG   ORTHOLOGY: K04851
Entry
K04851                      KO                                     

Name
CACNA1D, CAV1.3
Definition
voltage-dependent calcium channel L type alpha-1D
Pathway
ko04010  MAPK signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04218  Cellular senescence
ko04260  Cardiac muscle contraction
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04361  Axon regeneration
ko04530  Tight junction
ko04713  Circadian entrainment
ko04723  Retrograde endocannabinoid signaling
ko04724  Glutamatergic synapse
ko04725  Cholinergic synapse
ko04726  Serotonergic synapse
ko04727  GABAergic synapse
ko04728  Dopaminergic synapse
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04921  Oxytocin signaling pathway
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04927  Cortisol synthesis and secretion
ko04929  GnRH secretion
ko04930  Type II diabetes mellitus
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko04973  Carbohydrate digestion and absorption
ko05010  Alzheimer disease
ko05020  Prion disease
ko05031  Amphetamine addiction
ko05410  Hypertrophic cardiomyopathy
ko05412  Arrhythmogenic right ventricular cardiomyopathy
ko05414  Dilated cardiomyopathy
Disease
H01603  Primary aldosteronism
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04020 Calcium signaling pathway
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04024 cAMP signaling pathway
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04022 cGMP-PKG signaling pathway
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
 09140 Cellular Processes
  09143 Cell growth and death
   04218 Cellular senescence
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09144 Cellular community - eukaryotes
   04530 Tight junction
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
 09150 Organismal Systems
  09152 Endocrine system
   04911 Insulin secretion
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04929 GnRH secretion
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04912 GnRH signaling pathway
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04921 Oxytocin signaling pathway
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04935 Growth hormone synthesis, secretion and action
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04924 Renin secretion
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04925 Aldosterone synthesis and secretion
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04927 Cortisol synthesis and secretion
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09153 Circulatory system
   04260 Cardiac muscle contraction
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04261 Adrenergic signaling in cardiomyocytes
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04270 Vascular smooth muscle contraction
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09154 Digestive system
   04973 Carbohydrate digestion and absorption
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09156 Nervous system
   04724 Glutamatergic synapse
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04727 GABAergic synapse
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04725 Cholinergic synapse
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04728 Dopaminergic synapse
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04726 Serotonergic synapse
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04723 Retrograde endocannabinoid signaling
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09158 Development and regeneration
   04361 Axon regeneration
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09159 Environmental adaptation
   04713 Circadian entrainment
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   05020 Prion disease
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09165 Substance dependence
   05031 Amphetamine addiction
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09166 Cardiovascular disease
   05410 Hypertrophic cardiomyopathy
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   05412 Arrhythmogenic right ventricular cardiomyopathy
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   05414 Dilated cardiomyopathy
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
  09167 Endocrine and metabolic disease
   04930 Type II diabetes mellitus
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
   04934 Cushing syndrome
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
Ion channels [BR:ko04040]
 Voltage-gated cation channels
  Calcium channel, voltage-gated (Cav)
   K04851  CACNA1D, CAV1.3; voltage-dependent calcium channel L type alpha-1D
Other DBs
GO: 0005245
TC: 1.A.1.11.1 1.A.1.11.20 1.A.1.11.21
Genes
HSA: 776(CACNA1D)
PTR: 460447(CACNA1D)
PPS: 100975108(CACNA1D)
GGO: 101140987(CACNA1D)
PON: 100453904(CACNA1D)
NLE: 100600997(CACNA1D)
MCC: 693924(CACNA1D)
MCF: 102138213(CACNA1D)
CSAB: 103227762(CACNA1D)
RRO: 104672388(CACNA1D)
RBB: 108515198(CACNA1D)
CJC: 100397940(CACNA1D)
SBQ: 101043152(CACNA1D)
MMU: 12289(Cacna1d)
MCAL: 110309492(Cacna1d)
MPAH: 110325961(Cacna1d)
RNO: 29716(Cacna1d)
MUN: 110547567(Cacna1d)
CGE: 100772497(Cacna1d)
NGI: 103749025(Cacna1d)
HGL: 101714832(Cacna1d)
CCAN: 109674812(Cacna1d)
OCU: 100327259(CACNA1D)
TUP: 102484770(CACNA1D)
CFA: 484724(CACNA1D)
VVP: 112910069(CACNA1D)
AML: 100467700(CACNA1D)
UMR: 103674739(CACNA1D)
UAH: 113256986(CACNA1D)
ORO: 101383514(CACNA1D)
ELK: 111143738
FCA: 101088394(CACNA1D)
PTG: 102958456(CACNA1D)
PPAD: 109247930(CACNA1D)
AJU: 106986998(CACNA1D)
BTA: 408013(CACNA1D)
BOM: 102271623(CACNA1D)
BIU: 109576190(CACNA1D)
BBUB: 102405249(CACNA1D)
CHX: 102174706(CACNA1D)
OAS: 101106371(CACNA1D)
SSC: 100511102(CACNA1D)
CFR: 102504854(CACNA1D)
CDK: 105093176(CACNA1D)
BACU: 103001906(CACNA1D)
LVE: 103074544(CACNA1D)
OOR: 101276749(CACNA1D)
DLE: 111174277(CACNA1D)
PCAD: 102976068(CACNA1D)
ECB: 100051186(CACNA1D)
EPZ: 103560754
EAI: 106822066(CACNA1D)
MYB: 102259218(CACNA1D)
MYD: 102761441(CACNA1D)
MNA: 107534931(CACNA1D)
HAI: 109395944(CACNA1D)
DRO: 112301160(CACNA1D)
PALE: 102888351(CACNA1D)
RAY: 107516535(CACNA1D)
MJV: 108402355(CACNA1D)
LAV: 100659992(CACNA1D)
TMU: 101357085
MDO: 100014450(CACNA1D)
SHR: 100919750(CACNA1D)
PCW: 110197022(CACNA1D)
OAA: 100077296(CACNA1D)
GGA: 395895(CACNA1D)
MGP: 100545748(CACNA1D)
CJO: 107319871(CACNA1D)
NMEL: 110404743(CACNA1D)
APLA: 101803307(CACNA1D)
ACYG: 106048937(CACNA1D)
TGU: 100226925(CACNA1D)
LSR: 110471933(CACNA1D)
SCAN: 103816992(CACNA1D)
GFR: 102035179(CACNA1D)
FAB: 101819434(CACNA1D)
PHI: 102103301(CACNA1D)
PMAJ: 107210294(CACNA1D)
CCAE: 111935128(CACNA1D)
CCW: 104683258(CACNA1D)
ETL: 114058704(CACNA1D)
FPG: 101912795(CACNA1D)
FCH: 102054190(CACNA1D)
CLV: 102091108(CACNA1D)
EGZ: 104126731(CACNA1D)
NNI: 104009116 104010825(CACNA1D)
ACUN: 113484825(CACNA1D)
PADL: 103925489(CACNA1D)
AAM: 106488627(CACNA1D)
ASN: 102373960(CACNA1D)
AMJ: 102576817(CACNA1D)
PSS: 102447276(CACNA1D)
CMY: 102934282(CACNA1D)
CPIC: 101951786(CACNA1D)
ACS: 100554865(cacna1d)
PVT: 110084495(CACNA1D)
PBI: 103056075(CACNA1D)
PMUR: 107287678(CACNA1D)
PMUA: 114591684(CACNA1D)
GJA: 107116832(CACNA1D)
XLA: 100462912(cacna1d.L) 108704388
NPR: 108786047(CACNA1D)
DRE: 403310(cacna1da) 403311(cacna1db)
IPU: 108265454(cacna1d) 108281043
PHYP: 113533266(cacna1d) 113539515
AMEX: 103033357(cacna1d) 103043956
EEE: 113579158 113580442(cacna1d)
TRU: 101066777(cacna1d) 101070235
NCC: 104942817 104946163(cacna1d)
MZE: 101474865(cacna1d) 101485620
ONL: 100693494 100712099(cacna1d)
OLA: 101157531 101171831(cacna1d)
XMA: 102234425(cacna1d)
XCO: 114135515 114148180(cacna1d)
PRET: 103465120 103468016(cacna1d)
CVG: 107086672(cacna1d) 107094760
NFU: 107385116 107390617(cacna1d)
KMR: 108236775(cacna1d) 108247381
ALIM: 106513069(cacna1d) 106516186
LCF: 108886531 108891636(cacna1d)
HCQ: 109517788(cacna1d) 109522320
BPEC: 110168588 110174734(cacna1d)
MALB: 109951925 109970859(cacna1d)
ELS: 105006991 105007355(cacna1d)
SFM: 108925619(cacna1d) 108933838
PKI: 111833375(cacna1d) 111852542
LCM: 102360815(CACNA1D)
CMK: 103185068(cacna1d)
RTP: 109930589(cacna1d)
BFO: 118415799
CIN: 100184376
APLC: 110974142
SKO: 100371433
DME: Dmel_CG4894(Ca-alpha1D)
DER: 6543266
DSE: 6613668
DSI: Dsimw501_GD24041(Dsim_GD24041)
DSR: 110186075
DPE: 6598125
DMN: 108161670
DWI: 6643675
DAZ: 108611419
DNV: 115564037
DHE: 111594149
MDE: 101899996
LCQ: 111687187
AAG: 5574639
AALB: 109415132
AME: 100578899
BIM: 100746891
BTER: 100649439
CCAL: 108624459
OBB: 114871919
SOC: 105195131
MPHA: 105827888
AEC: 105144165
PBAR: 105427526
VEM: 105568891
HST: 105183370
DQU: 106749620
CFO: 105255351
LHU: 105672748
PGC: 109853346
OBO: 105280692
PCF: 106788672
NVI: 100119154
CSOL: 105365750
MDL: 103575476
TCA: 659557
DPA: 109541068
ATD: 109601172
NVL: 108568734
PXY: 105386242
API: 100160955
DNX: 107169074
AGS: 114121007
RMD: 113559335
BTAB: 109041122
CLEC: 106672043
ZNE: 110839478
PVM: 113811306
TUT: 107359653
DPTE: 113792829
CEL: CELE_C48A7.1(egl-19)
CBR: CBG05858(Cbr-egl-19)
BMY: Bm1_39550
PCAN: 112571409
CRG: 105345994
MYI: 110461243
OBI: 106872359
LAK: 106176729
DGT: 114521657
CRE: CHLREDRAFT_192415(CAV1)
 » show all
Reference
  Authors
Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nurnberg G, Ali A, Ahmad I, Sinnegger-Brauns MJ, Brandt N, Engel J, Mangoni ME, Farooq M, Khan HU, Nurnberg P, Striessnig J, Bolz HJ
  Title
Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness.
  Journal
Nat Neurosci 14:77-84 (2011)
DOI:10.1038/nn.2694
Reference
PMID:1309948
  Authors
Seino S, Chen L, Seino M, Blondel O, Takeda J, Johnson JH, Bell GI
  Title
Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells.
  Journal
Proc Natl Acad Sci U S A 89:584-8 (1992)
DOI:10.1073/pnas.89.2.584
  Sequence
[hsa:776]

KEGG   ORTHOLOGY: K04853
Entry
K04853                      KO                                     

Name
CACNA1F, CAV1.4
Definition
voltage-dependent calcium channel L type alpha-1F
Pathway
ko04010  MAPK signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04260  Cardiac muscle contraction
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04723  Retrograde endocannabinoid signaling
ko04725  Cholinergic synapse
ko04726  Serotonergic synapse
ko04727  GABAergic synapse
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04921  Oxytocin signaling pathway
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04927  Cortisol synthesis and secretion
ko04929  GnRH secretion
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko05010  Alzheimer disease
ko05020  Prion disease
ko05410  Hypertrophic cardiomyopathy
ko05412  Arrhythmogenic right ventricular cardiomyopathy
ko05414  Dilated cardiomyopathy
Disease
H00481  Cone-rod dystrophy and cone dystrophy
H00690  Aland Island eye disease
H00787  Congenital stationary night blindness
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04020 Calcium signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04024 cAMP signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04022 cGMP-PKG signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
 09150 Organismal Systems
  09152 Endocrine system
   04911 Insulin secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04929 GnRH secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04912 GnRH signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04921 Oxytocin signaling pathway
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04935 Growth hormone synthesis, secretion and action
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04924 Renin secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04925 Aldosterone synthesis and secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04927 Cortisol synthesis and secretion
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09153 Circulatory system
   04260 Cardiac muscle contraction
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04261 Adrenergic signaling in cardiomyocytes
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04270 Vascular smooth muscle contraction
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09156 Nervous system
   04727 GABAergic synapse
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04725 Cholinergic synapse
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04726 Serotonergic synapse
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   04723 Retrograde endocannabinoid signaling
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   05020 Prion disease
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09166 Cardiovascular disease
   05410 Hypertrophic cardiomyopathy
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   05412 Arrhythmogenic right ventricular cardiomyopathy
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
   05414 Dilated cardiomyopathy
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
Ion channels [BR:ko04040]
 Voltage-gated cation channels
  Calcium channel, voltage-gated (Cav)
   K04853  CACNA1F, CAV1.4; voltage-dependent calcium channel L type alpha-1F
Other DBs
GO: 0005245
TC: 1.A.1.11.11
Genes
HSA: 778(CACNA1F)
PTR: 740711(CACNA1F)
PPS: 100988624(CACNA1F)
GGO: 101131714(CACNA1F)
PON: 100431752(CACNA1F)
NLE: 100590475(CACNA1F)
MCC: 715787(CACNA1F)
MCF: 102119841(CACNA1F)
CSAB: 103231971(CACNA1F)
RRO: 104661816(CACNA1F)
RBB: 108521361
CJC: 100386041(CACNA1F)
SBQ: 101034685(CACNA1F)
MMU: 54652(Cacna1f)
MCAL: 110286673(Cacna1f)
MPAH: 110313596(Cacna1f)
RNO: 114493(Cacna1f)
MUN: 110561910(Cacna1f)
CGE: 100757994(Cacna1f)
NGI: 103741673(Cacna1f)
HGL: 101722090(Cacna1f)
CCAN: 109697195(Cacna1f)
OCU: 100357261(CACNA1F)
TUP: 102482779(CACNA1F)
CFA: 480915(CACNA1F)
VVP: 112907237(CACNA1F)
AML: 100468661(CACNA1F)
UMR: 103667625(CACNA1F)
UAH: 113265950(CACNA1F)
ORO: 101364481(CACNA1F)
ELK: 111150407
FCA: 101080870(CACNA1F)
PTG: 102950547(CACNA1F)
PPAD: 109248097(CACNA1F)
AJU: 106988999(CACNA1F)
BTA: 509779(CACNA1F)
BOM: 102286805(CACNA1F)
BIU: 109554975(CACNA1F)
BBUB: 102407399(CACNA1F)
CHX: 102189746(CACNA1F)
OAS: 101104552(CACNA1F)
SSC: 100514745(CACNA1F)
CFR: 102504151(CACNA1F)
CDK: 105103284(CACNA1F)
BACU: 102998540(CACNA1F)
LVE: 103082192(CACNA1F)
OOR: 101281199(CACNA1F)
DLE: 111169490(CACNA1F)
PCAD: 102992313(CACNA1F)
ECB: 100062861(CACNA1F)
EPZ: 103543955(CACNA1F)
EAI: 106826963(CACNA1F)
MYB: 102260789(CACNA1F)
MYD: 102771414(CACNA1F)
MNA: 107541372(CACNA1F)
HAI: 109374806(CACNA1F)
DRO: 112322357(CACNA1F)
PALE: 102893611(CACNA1F)
RAY: 107514999(CACNA1F)
MJV: 108404213(CACNA1F)
LAV: 100674649(CACNA1F)
TMU: 101340818
MDO: 100019531(CACNA1F)
SHR: 100927554(CACNA1F)
PCW: 110201034(CACNA1F)
OAA: 100075939(CACNA1F)
LSR: 110482322
FAB: 101817703
PHI: 102111116(CACNA1F)
FPG: 101922071
FCH: 102046341
CLV: 102089966
AAM: 106493905(CACNA1F)
ASN: 102368804(CACNA1F)
AMJ: 102563169(CACNA1F)
CPIC: 101934179(CACNA1F)
ACS: 100565753(cacna1f)
PVT: 110078615(CACNA1F)
PBI: 103051695(CACNA1F)
PMUR: 107284195(CACNA1F)
PMUA: 114587594(CACNA1F)
GJA: 107117359
XLA: 100462913(cacna1f.L)
XTR: 100485906(cacna1f)
NPR: 108788491
DRE: 559964(cacna1fb) 793708(cacna1fa)
IPU: 108265065 108265094(cacna1f)
EEE: 113578747(cacna1f) 113579098
TRU: 101077620(cacna1f) 101079199
MZE: 101480057
CVG: 107095949(cacna1f) 107099706
NFU: 107390498(cacna1f) 107391407
ALIM: 106519282(cacna1f) 106523414 106533880
AOCE: 111580242
CSEM: 103384398 103385395(cacna1f)
HCQ: 109510493 109512986(cacna1f)
BPEC: 110154433 110164475(cacna1f)
MALB: 109953071
SASA: 106572493
OTW: 112221526
SALP: 111966955
LCM: 102353236(CACNA1F)
 » show all
Reference
  Authors
Lee A, Wang S, Williams B, Hagen J, Scheetz TE, Haeseleer F
  Title
Characterization of Cav1.4 complexes (alpha11.4, beta2, and alpha2delta4) in HEK293T cells and in the retina.
  Journal
J Biol Chem 290:1505-21 (2015)
DOI:10.1074/jbc.M114.607465
  Sequence
[hsa:778]
Reference
PMID:9662399
  Authors
Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wutz K, Gutwillinger N, Ruther K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A
  Title
An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness.
  Journal
Nat Genet 19:260-3 (1998)
DOI:10.1038/940
  Sequence
[hsa:778]

KEGG   ORTHOLOGY: K04857
Entry
K04857                      KO                                     

Name
CACNA1S, CAV1.1
Definition
voltage-dependent calcium channel L type alpha-1S
Pathway
ko04010  MAPK signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04260  Cardiac muscle contraction
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04723  Retrograde endocannabinoid signaling
ko04725  Cholinergic synapse
ko04726  Serotonergic synapse
ko04727  GABAergic synapse
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04921  Oxytocin signaling pathway
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04927  Cortisol synthesis and secretion
ko04929  GnRH secretion
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko05010  Alzheimer disease
ko05020  Prion disease
ko05410  Hypertrophic cardiomyopathy
ko05412  Arrhythmogenic right ventricular cardiomyopathy
ko05414  Dilated cardiomyopathy
Disease
H00215  Periodic paralysis
H00746  Hypokalemic periodic paralysis (HypoPP)
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04020 Calcium signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04024 cAMP signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04022 cGMP-PKG signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
 09150 Organismal Systems
  09152 Endocrine system
   04911 Insulin secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04929 GnRH secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04912 GnRH signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04921 Oxytocin signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04935 Growth hormone synthesis, secretion and action
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04924 Renin secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04925 Aldosterone synthesis and secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04927 Cortisol synthesis and secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09153 Circulatory system
   04260 Cardiac muscle contraction
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04261 Adrenergic signaling in cardiomyocytes
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04270 Vascular smooth muscle contraction
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09156 Nervous system
   04727 GABAergic synapse
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04725 Cholinergic synapse
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04726 Serotonergic synapse
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04723 Retrograde endocannabinoid signaling
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   05020 Prion disease
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09166 Cardiovascular disease
   05410 Hypertrophic cardiomyopathy
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   05412 Arrhythmogenic right ventricular cardiomyopathy
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   05414 Dilated cardiomyopathy
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
Ion channels [BR:ko04040]
 Voltage-gated cation channels
  Calcium channel, voltage-gated (Cav)
   K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
Other DBs
GO: 0005245
TC: 1.A.1.11.2
Genes
HSA: 779(CACNA1S)
PTR: 469635(CACNA1S)
PPS: 100982136(CACNA1S)
GGO: 101150507(CACNA1S)
PON: 100433948(CACNA1S)
NLE: 100589614(CACNA1S)
MCC: 708706(CACNA1S)
MCF: 102131553(CACNA1S)
CSAB: 103230339(CACNA1S)
RRO: 104661868(CACNA1S)
RBB: 108545075(CACNA1S)
CJC: 100390112(CACNA1S)
SBQ: 101042219(CACNA1S)
MMU: 12292(Cacna1s)
MCAL: 110296075(Cacna1s)
MPAH: 110322010(Cacna1s)
RNO: 682930(Cacna1s)
MUN: 110548425(Cacna1s)
CGE: 100765508(Cacna1s)
NGI: 103731814(Cacna1s)
HGL: 101726232(Cacna1s)
CCAN: 109696593
OCU: 100009585(CACNA1S)
TUP: 102481015(CACNA1S)
CFA: 490244(CACNA1S)
VVP: 112934538(CACNA1S)
AML: 100472835(CACNA1S)
UMR: 103657769(CACNA1S)
UAH: 113242563(CACNA1S)
ORO: 101385947(CACNA1S)
ELK: 111150995
FCA: 654399(CACNA1S)
PTG: 102949808(CACNA1S)
PPAD: 109256096(CACNA1S)
AJU: 106974264(CACNA1S)
BTA: 100337204(CACNA1S)
BOM: 102272241(CACNA1S)
BBUB: 102397191(CACNA1S)
CHX: 102176151(CACNA1S)
OAS: 101108767(CACNA1S)
SSC: 100622149(CACNA1S)
CFR: 102507309(CACNA1S)
CDK: 105090835(CACNA1S)
BACU: 103014409(CACNA1S)
LVE: 103090575(CACNA1S)
OOR: 101275416(CACNA1S)
DLE: 111168340(CACNA1S)
PCAD: 102987099(CACNA1S)
ECB: 100034092(CACNA1S)
EPZ: 103565109(CACNA1S)
EAI: 106823553(CACNA1S)
MYB: 102243265(CACNA1S)
MYD: 102760374(CACNA1S)
MNA: 107536018(CACNA1S)
HAI: 109380439(CACNA1S)
DRO: 112318756(CACNA1S)
PALE: 102896136(CACNA1S)
RAY: 107513628(CACNA1S)
MJV: 108396001(CACNA1S)
LAV: 100673089(CACNA1S)
TMU: 101343945
MDO: 100013684(CACNA1S)
SHR: 100917433(CACNA1S)
PCW: 110219570(CACNA1S)
OAA: 100093447(CACNA1S)
GGA: 395985(CATSPER2)
MGP: 100547445(CACNA1S)
CJO: 107324611(CACNA1S)
NMEL: 110388201(CACNA1S)
APLA: 101801311(CACNA1S)
ACYG: 106046137(CACNA1S)
TGU: 100220193(CACNA1S)
LSR: 110469152(CACNA1S)
SCAN: 103822432(CACNA1S)
GFR: 102037957(CACNA1S)
FAB: 101821759(CACNA1S)
PHI: 102111358(CACNA1S)
PMAJ: 107214754(CACNA1S)
CCAE: 111939717(CACNA1S)
CCW: 104692446(CACNA1S)
ETL: 114064775(CACNA1S)
FPG: 101914764(CACNA1S)
FCH: 102058184(CACNA1S)
CLV: 102092229(CACNA1S)
EGZ: 104122032(CACNA1S)
NNI: 104011070(CACNA1S)
ACUN: 113488965(CACNA1S)
PADL: 103913818(CACNA1S)
AAM: 106500235(CACNA1S)
ASN: 102377229(CACNA1S)
AMJ: 102563699(CACNA1S)
PSS: 102453880
CPIC: 101932307(CACNA1S)
ACS: 100551605(cacna1s)
PVT: 110085291(CACNA1S)
PBI: 103055781(CACNA1S)
PMUR: 107289042(CACNA1S)
TSR: 106549619(CACNA1S)
PMUA: 114599194(CACNA1S)
GJA: 107110972(CACNA1S)
XLA: 100381134(cacna1s.S) 108707491
XTR: 100485035(cacna1s)
NPR: 108804869(CACNA1S)
DRE: 405791(cacna1sb) 570683(cacna1sa)
CCAR: 109068176
IPU: 108254927 108266034(CAC1S)
PHYP: 113526802(cacna1s)
EEE: 113581084 113586976(cacna1s)
LCO: 104932670(cacna1s)
NCC: 104956859(cacna1s)
MZE: 101479917(cacna1s)
ONL: 100704349(cacna1s)
XMA: 102237099(cacna1s)
XCO: 114148648(cacna1s)
PRET: 103467335(cacna1s)
CVG: 107086768(cacna1s)
NFU: 107390862(cacna1s)
KMR: 108244587(cacna1s)
ALIM: 106525038(cacna1s)
AOCE: 111564440(cacna1s) 111586752
POV: 109630550(cacna1s)
BPEC: 110164965(cacna1s)
MALB: 109968827(cacna1s)
OTW: 112255319
SFM: 108931184 108933625(cacna1s)
LCM: 102356715(CACNA1S)
CMK: 103190861
RTP: 109922317
CRG: 105331673
 » show all
Reference
  Authors
Pirone A, Schredelseker J, Tuluc P, Gravino E, Fortunato G, Flucher BE, Carsana A, Salvatore F, Grabner M
  Title
Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit.
  Journal
Am J Physiol Cell Physiol 299:C1345-54 (2010)
DOI:10.1152/ajpcell.00008.2010
  Sequence
[hsa:779]
Reference
PMID:8004673
  Authors
Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G, et al.
  Title
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.
  Journal
Cell 77:863-8 (1994)
DOI:10.1016/0092-8674(94)90135-X
  Sequence
[hsa:779]

DBGET integrated database retrieval system